Tumor-associated myeloid cells can be activated in vitro and in vivo to mediate antitumor effects

A.L. Rakhmilevich, M.J. Baldeshwiler, T.J. Van De Voort, M.A.R. Felder, R.K. Yang, N.A. Kalogriopoulos, D.S. Koslov, N. van Rooijen, P.M. Sondel

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1683-1697
JournalCancer Immunology and Immunotherapy
Issue number10
Publication statusPublished - 2012

Cite this